|1.||Hackeng, T M: 1 article (10/2004)|
|2.||Fernández, J A: 1 article (10/2004)|
|3.||Heeb, M J: 1 article (10/2004)|
|4.||Koenen, R R: 1 article (10/2004)|
|5.||Gomes, Lucio: 1 article (06/2004)|
|6.||Rosing, Jan: 1 article (06/2004)|
|7.||Hackeng, Tilman M: 1 article (06/2004)|
|8.||Tans, Guido: 1 article (06/2004)|
|9.||Koenen, Rory R: 1 article (06/2004)|
|10.||Giri, T K: 1 article (07/2000)|
10/01/2004 - "Because protein S-Heerlen is not associated with thrombosis, we investigated whether PS-C4BP is directly anticoagulant in plasma and whether PS-Heerlen-C4BP has enhanced direct anticoagulant activity. "
07/15/2000 - "These in vitro results suggest a possible mechanism of synergy between protein S Heerlen and factor V Leiden that might be involved in the pathogenesis of thrombosis in individuals carrying both genetic traits. "
|2.||Venous Thrombosis (Deep-Vein Thrombosis)
06/01/2004 - "If not, the reduction of free protein S levels in heterozygous protein S Heerlen-carriers combined with (low) normal total protein S levels apparently minimally affects the total anticoagulant activity of protein S (APC-cofactor and APC-independent activity) and hence is not associated with increased risk of venous thrombosis."
|3.||Protein S Deficiency (Deficiency, Protein S)
|2.||factor V Leiden